JAX Home

Kevin J. Anderson, Ph.D.

Postdoctoral Associate

Integrates biomechanical and genomic approaches towards the analysis of brain tumor heterogeneity and disease evolution.

Visit The Verhaak Lab

Contact me at: 860-837-2474

Connect with me:

About Kevin J. Anderson, Ph.D.

Dr. Anderson received his Ph.D. in Biomedical Engineering from Cornell University. For his thesis research he adapted a multiscale numerical simulation towards the analysis of the initial behavior of circulating tumor cell aggregates interacting with activated endothelium. Previously, he received his B.S. in Biomedical Engineering at the University of Alabama at Birmingham.

Download CV

Education and experience

Education

The Jackson Laboratory
Postdoctoral fellow
Adv: Dr. Roel Verhaak
2017-present

Cornell University
Ph.D., Biomedical Engineering
Adv: Dr. Michael King
2011-2017

University of Alabama at Birmingham
B.S., Biomedical Engineering
2007-2011

Experience

Vanderbilt University
Postdoctoral Research Scholar
2017

Cornell University
Graduate Research Assistant
2011-2017

Selected Publications

Anderson KJ, de Guillebon A, Hughes AD, Wang W, King MR. Effect of circulating tumor cell aggregate configuration on hemodynamic transport and wall contact. Math Biosci 294(Dec):181-194, 2017.

View full List of Publications

Research HighlightJune 11, 2018
Measuring tumor heterogeneity for better, evolution-based cancer treatment strategies
JAX Associate Professor Jeffrey Chuang, Ph.D., has been awarded a five-year grant totaling $2,650,484 from the National Cancer Institute for research that could pave the way for the first evolution-based approaches to cancer treatment.
- Cancer/Tumors
- Cancer
Press ReleaseApril 30, 2018
Detecting human genome structural variation with long read sequencing
A research team led by Chia-lin Wei is using technology to more easily detect and classify important types of difficult-to-find genomic alterations, known as structural variants.
- Genetic Tools
- Genetics and Genomics
Press ReleaseApril 23, 2018
The role of extra DNA in cancer evolution and therapy resistance
New research is providing a better understanding of the processes underlying cell-to-cell differences within glioblastoma tumors — a crucial finding because these differences contribute to therapy resistance.
- Cancer/Tumors
- Cancer
Tech CornerApril 05, 2018
Finding the signal in the noise
GeneWeaver is a powerful web-based software system that combines a genomics data repository with powerful analysis tools.
- Genetic Tools
- Genetics and Genomics

Tech CornerMay 04, 2018
What's new in cancer research?
The field of cancer immunotherapy research is extremely exciting, yet still somewhat mysterious, as researchers grapple with the fine-tuning of patient response.
- Cancer/Tumors
- Cancer
Search MagazineApril 27, 2018
Finding precise cures for cancer
At JAX's new speaker event series, JAXtaposition, two scientific leaders shared how the Maine Cancer Genomics Initiative and JAX’s cutting-edge genomic testing is giving physicians access to the most advanced precision cancer care for their patients.
- Cancer/Tumors
- Cancer
Tech CornerApril 10, 2018
Cancer and its immune environment bioprinted and reproduced live and in 3D
New 3D bioprinting technique creates a platform for precision immunotherapy study.
Press ReleaseApril 05, 2018
DNA sequence alterations linked to type 2 diabetes genes and mechanisms
Michael Stitzel, Ph.D., a Jackson Laboratory assistant professor, is the senior author of a paper in the American Journal of Human Genetics identifying new genetic clues to type 2 diabetes mechanisms.